Multiple sclerosis symptoms at onset linked to long-term disability
Multiple sclerosis (MS) research has uncovered a potential link between certain initial symptoms and long-term disability ...
News Medical1h
Study links initial symptoms to long-term disability in multiple sclerosis
In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes.
Armed robbery in Revesby7h
Cholesterol Drug Ineffective for Multiple Sclerosis Treatment
Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...
AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS 2024 Paris, 23 September 2024, 5.45pm CET AB Science SA (Euronext - ...
News Medical on MSN6d
$1 Million Grant to Fund Research of Nerve Regeneration in Multiple Sclerosis Patients
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
New research provides insights into how the brain regenerates lost myelin
The neurons of the brain are protected by an insulating layer called myelin. In certain diseases like multiple sclerosis, ...
Business Wire6d
New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis
“If not treated early upon diagnosis, multiple sclerosis can lead to significant, irreversible brain volume loss and cognitive decline,” said Jeffrey Cohen, MD, Mellen Center for Multiple Sclerosis, ...
BioTechniques4d
Biomarkers for predicting multiple sclerosis progression identified
Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...
New scans reveal how the brain re-organises during pregnancy
Researchers have previously taken images of pregnant women's brains, but these can miss temporary changes in the brain that ...
Bristol Myers Squibb Presents Data For Multiple Sclerosis Drug Zeposia, Shows Long-Term Efficacy
Bristol Myers Squibb announces Phase 3 DAYBREAK trial data showing Zeposia (ozanimod) reduces brain volume loss in relapsing multiple sclerosis patients.